Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices 52495 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an 

e-mail to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Program of Cancer Registries 

Cancer Surveillance System (OMB no. 

0920–0469 exp. Date 1/31/2010)— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

In 1992, Congress passed the Cancer 

Registries Amendment Act, which 

established the National Program of 

Cancer Registries (NPCR). The NPCR 

provides support for central cancer 

registries (CCR) that collect, manage and 

analyze data about cancer cases. The 

NPCR-funded CCR, which are located in 

states, the District of Columbia, and U.S. 

territories, report information to CDC 

annually through the National Program 

of Cancer Registries Cancer Surveillance 

System (NPCR CSS) (OMB No. 0920– 

0469, exp. 1/31/2010). CDC plans to 

request OMB approval to continue 

collecting this information for three 

years. 

The NPCR CSS allows CDC to collect, 

aggregate, evaluate and disseminate 

cancer incidence data at the national 

level, and is the primary source of 

information for United States Cancer 

Statistics (USCS), which CDC has 

published annually since 2002. The 

NPCR CSS also allows CDC to monitor 

cancer trends over time, describe 

geographic variation in cancer incidence 

throughout the country, and provide 

incidence data on minority populations 

and rare cancers. These activities and 

analyses further support CDC’s planning 

and evaluation efforts for State and 

national cancer control and prevention. 

In addition, datasets can be made 

available for secondary analysis. 

Each responding CCR is asked to 

report a cumulative file containing 

incidence data from the first diagnosis 

year for which the cancer registry 

collected data with the assistance of 

NPCR funds (e.g., 1995) through 12 

months past the close of the most recent 

diagnosis year (e.g., 2007). Because 

cancer incidence data are already 

collected and aggregated at the State 

level the additional burden of reporting 

the information to CDC is small. 

Information is transmitted to CDC 

electronically once per year. 

The Revision request will include 

changes. First, data definitions will be 

updated to reflect changes in national 

standards for cancer diagnosis and 

coding. In addition, the number of 

respondents will decrease. Respondents 

will be 45 State-based CCR, the CCR of 

the District of Columbia, the CCR of 

Puerto Rico, and the CCR that aggregates 

information from 10 flag territories and 

freely associated States in the Pacific 

Islands. States that receive sole funding 

from the National Cancer Institute are 

not included as respondents. The 

adjusted number of respondents will 

result in a reduction in the total 

estimated burden hours for the NPCR 

CSS. The estimated burden per response 

will not change. 

There are no costs to respondents 

except their time. The total estimated 

annualized burden hours are 96. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Central Cancer Registries in States, Territories, and the District of Columbia .......................... 48 1 2 

Dated: October 5, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–24520 Filed 10–9–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0406] 

Agency Emergency Processing Under 

Office of Management and Budget 

Review; Tobacco Product 

Establishment Registration and 

Submission of Certain Health 

Information; Reopening of the 

Comment Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; reopening of the 

comment period. 

SUMMARY: The Food and Drug 

Administration (FDA) is reopening until 

October 26, 2009, the comment period 

for the notice published in the Federal 

Register of September 1, 2009 (74 FR 

45219). The document announced the 

proposed collection of information 

concerning the submission of tobacco 

product establishment registration and 

submission of certain health 

information, including ingredient listing 

and health related documents, as 

required by The Family Smoking 

Prevention and Tobacco Control Act 

(FSPTCA). The agency is reopening the 

comment period because FDA has 

reevaluated the expected launch date of 

the electronic portal and to allow 

interested persons additional time to 

review the proposed collection of 

information and submit comments. 

DATES: Fax written comments on the 

collection of information by October 26, 

2009. FDA is requesting approval of this 

emergency processing by November 2, 

2009. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

the Office of Management and Budget 

(OMB) recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–5806, or e-mailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–NEW. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of the Chief 

Information Officer (HFA–710), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–796– 

3794, e-mail: 

Jonnalynn.Capezzuto@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of September 1, 2009 

(74 FR 45219), FDA requested 

emergency processing of this proposed 

collection of information under section 


erowe on DSK5CLS3C1PROD with NOTICES
52496 Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices 

3507(j) of the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3507(j) and 5 

CFR 1320.13). On June 22, 2009, the 

President signed FSPTCA into law 

(Public Law 111–31). Section 101 of 

FSPTCA amends the Federal Food, 

Drug, and Cosmetic Act (the act) by 

adding, among other things, new 

sections 904 (21 U.S.C. 394) and 905 (21 

U.S.C. 395). 

FDA originally identified its plan to 

collect the information submission 

requirements of sections 905, 904(a)(1), 

and 904(a)(4) through a single electronic 

portal. In addition to the electronic 

portal, FDA also plans to provide a 

paper based form to collect this 

information for those individuals who 

choose not to use the electronic portal. 

FDA originally planned to launch the 

electronic portal for the collection of 

this information on October 1, 2009. 

FDA now plans to launch the electronic 

portal for the collection of this 

information on November 2, 2009. If 

FDA were to use the normal PRA 

clearance procedures, the availability of 

the electronic portal and the submission 

of information by respondents could not 

begin with adequate time to meet the 

respective statutory deadlines 

(December 22, 2009, for section 904, and 

December 31, 2009, for section 905). 

Dated: October 6, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–24543 Filed 10–9–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; DMID Clinical Research 

Operations and Management Support. 

Date: November 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Roosevelt Room, Rockville, 

MD 20852. 

Contact Person: Clayton C. Huntley, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID/DHHS, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892–7616, (301) 451–2570, 

chuntley@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Exploratory Investigation in 

Food Allergy (R21). 

Date: November 19–20, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Sujata Vijh, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892, 301–594–0985, 

vijhs@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 5, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24472 Filed 10–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Interagency Autism Coordinating 

Committee (IACC) Subcommittee for 

Planning the Annual Strategic Planning 

Process. 

The purpose of the Subcommittee for 

Planning the Annual Strategic Planning 

Process is to plan the process for 

annually updating the IACC Strategic 

Plan for Autism Spectrum Disorder 

Research. The Subcommittee meeting 

will be conducted as a telephone 

conference call. This meeting is open to 

the public through a conference call 

phone number. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of meeting: Subcommittee for 

planning the Annual Strategic Planning 

Process. 

Date: October 15, 2009. 

Time: 2 p.m. to 4 p.m. Eastern Time. 

Agenda: To discuss the outcome of the 

IACC Scientific Workshop that took place on 

September 30 and October 1, 2009. 

Conference Call: Dial: 888–455–2920. 

Access code: 1050786. 

Contact Person: Ms. Lina Perez, Office of 

Autism Research Coordination, Office of the 

Director, National Institute of Mental Health, 

NIH, 6001 Executive Boulevard, NSC, Room 

8200, Bethesda, MD 20892–9669. Phone: 

301–443–6040.E-mail: 

IACCPublicInquiries@mail.nih.gov. 

Please Note: The meeting will be open to 

the public through a conference call phone 

number. Individuals who participate using 

this service and who need special assistance, 

such as captioning of the conference call or 

other reasonable accommodations, should 

submit a request at least 4 days prior to the 

meeting. 

Members of the public who participate 

using the conference call phone number will 

be able to listen to the meeting but will not 

be heard. This phone call may end prior to 

or later than 4 p.m., depending on the needs 

of the subcommittee. 

This meeting is being published less than 

15 days prior to the meeting due to the 

timing limitations for the Subcommittee to 

review and discuss the outcomes from the 

IACC Workshop and to be able to present 

their proposals at the IACC meeting on 

October 23. 

Information about the IACC is available on 

the Web site: http://www.iacc.hhs.gov. 

Dated: October 5, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24473 Filed 10–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


erowe on DSK5CLS3C1PROD with NOTICES